Optimising treatment duration with immunomodulators to reduce overtreatment

Verifisert
National Institute for Health and Care Research
Type
Tilskudd
Frist
Utløpt 2. desember 2025
Program
Health Technology Assessment

Om ordningen

- Funding programme: Health Technology Assessment - Opening date: 2025-07-31 - Closing date: 2025-12-02

Our Health Technology Assessment (HTA) Programme is looking to fund research into optimising treatment duration with immunomodulators to reduce overtreatment.

Full eligibility, award value and application detail are published on the opportunity's own page: https://www.nihr.ac.uk/funding/optimising-treatment-duration-immunomodulators-reduce-overtreatment/2025255

Ofte stilte spørsmål

Hvem står bak Optimising treatment duration with immunomodulators to reduce overtreatment?
Optimising treatment duration with immunomodulators to reduce overtreatment er en tilskudd fra National Institute for Health and Care Research.
Hvordan søker man på Optimising treatment duration with immunomodulators to reduce overtreatment?
Du søker hos National Institute for Health and Care Research via lenken på denne siden. Virkely hjelper deg å skrive selve søknaden — fra organisasjonsnummer til ferdig tekst.

Skal du søke Optimising treatment duration with immunomodulators to reduce overtreatment?

Virkely hjelper deg å skrive søknaden — fra organisasjonsnummer til ferdig tekst. Ingen innlogging.

Start søknaden

Flere ordninger fra National Institute for Health and Care Research

Relaterte kategorier